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PCV16
SMOKING DEPENDENCY: AUDIT CARRIED 
OUT AMONG THE UNDER 25 GROUP 
Taïeb C, Myon E
Pierre Fabre SA, Boulogne Billancourt, France
OBJECTIVES: As part of an environment program (out-
comes program) on smoking cessation, it seemed inter-
esting to study young smokers under the age of twenty
ﬁve. METHOD: A special questionnaire was distributed
to them via the «Etudiant» supplement of a French
regional weekly newspaper (Tarn Libre), which they were
asked to return by post. RESULTS: The ﬁrst results con-
cerned the ﬁrst 50 questionnaires returned. Average age:
17.5 years; average weight: 56 kilos; average height: 
1.67m. In our sample, 92% were students, 86% declared
themselves to be exposed to other people’s smoke and
only 37% said they took part in a sporting activity. Age
at which tobacco dependency began was 13 years; 98%
smoked cigarettes—versus 2% a cigar or pipe); the
average daily consumption was 10 cigarettes; of these,
65% wished to stop smoking, but only 38% had already
made an attempt at smoking cessation. Only 30%,
however, said that they had been asked spontaneously by
their doctor about their desire to stop smoking (minimum
advice) In the Fagerström test, 48% had low or no depen-
dency; 48% had moderate dependency and only 2% had
heavy dependency. CONCLUSIONS: This pilot study
conﬁrmed that tobacco dependency is occurring at an
increasingly early age; that tobacco dependency in young
people is low or moderate, and that there is little man-
agement of tobacco dependency in young people by
doctors.
PCV17
RELATIONSHIP BETWEEN PATIENT BELIEFS
ABOUT MEDICATION AND SELF-REPORTED
MEDICATION ADHERENCE SIX MONTHS 
AFTER DISCHARGE FOR ACUTE 
CORONARY SYNDROMES
Stafkey DR, Erickson SR, Kline-Rogers EM, Smith DE,
Cooper JV, Chang A, Eagel KA
University of Michigan, Ann Arbor, MI, USA
OBJECTIVES: To describe patients’ beliefs about med-
ication six months after discharge for acute coronary 
syndrome (ACS) and to determine the relationship
between self-reported medication adherence and patients’
medication beliefs. METHODS: All patients discharged
with the diagnosis of ACS during a 6-month period from
a university afﬁliated hospital were administered a tele-
phone survey six months after discharge. The survey
included the Belief About Medication Questionnaire
(BMQ), the Morisky Adherence Scale (MAS), and items
about patient demographics, social support, number of
medications, and health status. The BMQ has 18 items
that generate four scales: Speciﬁc-Necessity (SN), Speciﬁc-
Concerns (SC), General-Harm (GH), and General-
Overuse (GO). The MAS is a 4-item scale providing a
single score. Both questionnaires use ﬁve response options
per item. Lower BMQ-scale scores indicate stronger
beliefs. Lower MAS scores indicate better adherence. Cor-
relation between independent variables and MAS were
conducted using Pearson’s rho; Student’s t-test was used
for bivariate analyses. A p < 0.05 was considered signif-
icant. RESULTS: To date, 25 patients have been inter-
viewed (goal of 75). The mean age was 63.4 (+12.6) years
with 67% male, 92% Caucasian, 56% with some or more
college education, 76% lived with 1 other person, and
40% indicated excellent or very good health. The mean
BMQ scale scores were: SN = 2.4 (+0.8), SC = 3.2 (+0.7),
GO = 3.3 (+0.7), and GH = 3.8 (+0.4). The mean MAS
was 1.3(+0.4), with 59.1% indicating nonadherence
(score > 1). The BMQ-SN was signiﬁcantly correlated
with the MAS (r = 0.47, p = 0.03). The BMQ-GH (r =
-0.3, p = 0.18) and social support (r = 0.4, p = 0.058)
trended toward signiﬁcant association. Bivariate analyses
showed no signiﬁcant association between independent
variables and the MAS, but trends were noted with the
same independent variables. CONCLUSION: Patients
with stronger belief of the necessity of medication and
strong social support report higher adherence with
cardiac medication. They did not think medications were
overused or harmful. Determining beliefs about medica-
tion may be helpful in developing interventions aimed at
improving adherence.
PCV18
A CONFIRMATORY FACTOR ANALYSIS
EVALUATION OF THE CORONARY HEART
DISEASE RISK FACTORS OF METABOLIC
SYNDROME AND THE EFFECTIVENESS OF 
THE CURRENT ATP III GUIDELINES FOR
IDENTIFICATION
Novak S, Stapleton LM, Litaker JR, Lawson KA
University of Texas at Austin, Austin,TX, USA
OBJECTIVES: The purpose of this study is to analyze 
the underlying associations between coronary risk factors
and the metabolic syndrome on a previously studied
cohort of 284 middle-aged Caucasian males from
Sweden. These associations were then placed in context
of current Adult Treatment Panel III guidelines for diag-
nosing metabolic syndrome and American College of
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Endocrinology guidelines for diagnosing insulin resis-
tance syndrome. METHODS: A conﬁrmatory factor
analysis was performed using EQS Multivariate Software
Version 5.7b with maximum likelihood estimation.
Hypertension, obesity, insulin resistance, cholesterol, and
hyperlipidemia were the latent factors studied. RESULTS:
Cholesterol was not signiﬁcantly associated (p < 0.05)
with either obesity (r = 0.015) or insulin resistance (r =
-0.042), giving further support to the possibility of mul-
tiple risk factors for predicting coronary heart disease in
addition to elevated LDL cholesterol. Signiﬁcant correla-
tions (p < 0.05) were noted between obesity and hyper-
lipidemia (r = 0.583), obesity and insulin resistance (r =
0.899), and insulin resistance and hyperlipidemia (r =
0.928). CONCLUSION: These associations are discussed
in the context that the average patient did not meet Adult
Treatment Panel III deﬁned criteria for metabolic syn-
drome. We suggest that more stringent guidelines such 
as those suggested by the American College of Endo-
crinology may be necessary to identify and diagnose the
pathophysiologic risk factors involved in the metabolic
syndrome. One suggestion may be to include an oral
glucose tolerance test to help in evaluation of insulin 
resistance. More stringent cut-offs for abnormal values of
triglycerides and HDL cholesterol may also be required.
We also suggest that research of the metabolic syndrome
may be better accomplished by focusing on individual
physiologic components rather than focusing on one
single etiology to quantify, which is an approach that has
been taken in previous research.
PCV19
SMOKING CESSATION: RELEVANCE IN THE
UNDER 25 GROUP
Taïeb C, Myon E
Pierre Fabre SA, Boulogne Billancourt, France
OBJECTIVES: As part of an outcomes program on
smoking cessation, we thought it relevant to evaluate in
smokers under 25 years of age the obstacles to cessation,
the level of dependency, the knowledge of tobacco depen-
dency and the propensity to pay for cessation treatment.
METHOD: For this pilot phase, an anonymous ques-
tionnaire was distributed in the Etudiant supplement 
of a French regional weekly newspaper (Tarn Libre).
RESULTS: Obstacle to cessation: lack of willpower
(51%), enjoyment of smoking (32%), force of habit
(46%) The level of dependency on tobacco was evaluated
using the Fagerström test: 48% had low dependency,
48% moderate dependency and 2% high dependency. In
general, our sample population had a good general
knowledge and understanding of tobacco use (number of
premature deaths per year, percentage of smokers in
France, cost of tobacco for health insurance). Average
daily tobacco expenses were €2.3 (roughly corresponding
to an average consumption of 10 cigarettes/day), and the
subjects declared themselves ready to pay around €83 to
stop smoking (€157 in older adults). This ﬁgure is rela-
tively low and is explained without doubt by an under-
estimation of the potential risks of tobacco dependency.
CONCLUSION: Young people are a population whose
dependency level is mainly low or moderate, a fact that
enables (with appropriate but generalized mobilization
(doctor, educator, pharmacist, family)) a smoking cessa-
tion attempt to succeed.
PCV20
DYSLIPIDEMIA PATTERNS AMONG HIGH 
RISK MEMBERS OF A MANAGED CARE
ORGANIZATION
Lewis BE1, McDonough KL2, Pethick N2, O’Donnell JC2
1AstraZeneca, Worcester, MA, USA; 2Astrazeneca, Wilmington,
DE, USA
OBJECTIVES: NCEP ATP III guidelines expanded indi-
cations for intensive cholesterol-lowering therapy by
focusing on primary prevention in individuals with mul-
tiple risk factors. This study examined the impact of
guidelines on pharmacologic treatment patterns in 
individuals at high risk for cardiovascular disease. A 
retrospective database study was conducted in a large
multi-site managed care organization. Speciﬁc objectives
were to: 1) determine prevalence of high-risk members;
2) assess existing LDL testing patterns; 3) assess patterns
of medication treatment: 4) assess the impact of ATP III
guidelines on lipid outcome; and 5) examine medication
possession ratios—Days supply of statin / (End date of
study—First prescription date) for goal achievers versus
non-achievers. METHODS: Medical, laboratory and
pharmacy records of members aged 18 years and over and
continuously enrolled for 30 months were reviewed to
identify individuals with a diagnosis of coronary artery
disease (CAD) or risk equivalent (one or more of the 
following: peripheral artery disease, abdominal aortic
aneurysm, symptomatic carotid artery disease, diabetes).
RESULTS: Of 422,914 members who met age and enroll-
ment criteria, 16,036 (3.8%) were high risk. 38.4% of
high-risk members had LDL tests during the observation
period. 38.1% of high-risk members received a prescrip-
tion for a cholesterol-lowering drug. The percentage 
of high-risk members that reached NCEP ATP Goal 
<100mg/dl LDL was 34.7%. Members with anti-
lipidemic prescriptions were signiﬁcantly more likely to
reach ATP III goal (42.2% vs. 26.6%) (measured by Test
of Proportion Z = 12.78). A Wilcoxon Rank Sum test
indicated that Risk and Risk EQ Ss who reached goal
were signiﬁcantly more likely to have a high Possession
Ratio than those who did not reach goal. CONCLU-
SIONS: Managed care provides numerous opportunities
to improve cardiovascular health through identiﬁcation
of high risk members, educating physicians on NCEP ATP
III guidelines; more aggressive testing and treatment,
patient compliance counseling and monitoring of goal
performance.
